Fomepizole Injection, 1.5 g/1.5 mL (1 g/mL), For Intravenous Infusion only, Rx only, Manufactured by: Emcure Pharmaceuticals Lt. for Sandoz Inc., Princeton, NJ 08540, NDC 0781-3182-73 and 0781-3182-84
Published April 15, 2015 · Recall initiated: March 9, 2015
Summary
FDA records drug Class II recall D-0431-2015, published April 15, 2015 and initiated March 9, 2015. Recalling firm: Navinta LLC; Status: Terminated; Reported quantity: 14,628 units; Lot: Lot #: VFMA 029, VFMA 030, VFMA 031, VFMA 032 Exp 4/15; VFMA 033, Exp 7/2016; VFMA 034, Exp 10/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Navinta LLC
- Distributor
- Nationwide
- Lot
- Lot #: VFMA 029, VFMA 030, VFMA 031, VFMA 032 Exp 4/15; VFMA 033, Exp 7/2016; VFMA 034, Exp 10/2017.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFexofenadine HCl Tablets, USP, 60 mg, Allergy, Antihistamine, Indoor and Outdoor Allergies, Non-Drowsy,April 15, 2015
- FDARose Medical Center (CO) Neonate D5 Bridge, Trophamine 3% Dextrose 5%, Additives: heparin PF 0.5 unit(s)/ml,April 15, 2015
- FDAAdventist Hinsdale Hospital (IL) Neonatal Starter: Troph 4%Dex5% ,Trophamine 4% Dextrose 5%, Additives:April 15, 2015
- FDACD123 (9F5) PE Catalog number 649453 Analyte Specific ReagentApril 8, 2015
- FDABio-CORE Cannula (Needle) SetApril 8, 2015
- FDAVarious Lots of Expel Drainage Catheter with TwistLoc Hub Biliary Drainage Catheter and Biliary DrainageApril 8, 2015
Questions about this recall
Was Fomepizole Injection, 1.5 g/1.5 mL (1 g/mL), For Intravenous Infusion only, Rx only, Manufactured by: Emcure Pharmaceuticals Lt. for Sandoz Inc., Princeton, NJ 08540, NDC 0781-3182-73 and 0781-3182-84 recalled?
Yes. FDA published recall D-0431-2015 on April 15, 2015. Reported hazard: Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.
What should I do if I have this product?
Voluntary: Firm initiated · Letter